Early research (Phase 1)Study completedNCT05970640
What this trial is testing
Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
Boehringer Ingelheim 64